Concepedia

Age-specific Interaction Risk

Age-Specific Interaction Risk is a pediatric pharmacological construct that denotes the differential likelihood and severity of drug interactions in children attributable to developmental and maturational factors unique to specific age groups, distinguishing it from adult-centric interaction models by incorporating ontogeny-dependent physiological and metabolic variations.

16

Publications

653

Citations

122

Authors

70

Institutions

Publications per year

2017–2026

2

Parents

Publications

16

The Interaction Between Age and Risk Factors for Diabetes and Prediabetes: A Community-Based Cross-Sectional Study

Zihui Yan, Mengjie Cai, Xu Han et al. · Diabetes Metabolic Syndrome and Obesity · 2023 · 100 citations · Full text

, , +12

Risk of Potential Drug-Drug Interactions among Brazilian Elderly

Silvia-Regina Secoli, Albert Figueras, Maria Lúcia Lebrão et al. · Drugs & Aging · 2010 · 91 citations

, , +14

The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs

Danielle Horyniak, Paul Dietze, Louisa Degenhardt et al. · Drug and Alcohol Dependence · 2013 · 62 citations · Full text

, , +8

Determinants of black-white differences in the risk of cerebral infarction. The National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.

Wayne H. Giles, Steven J. Kittner, J. Richard Hebel et al. · PubMed · 1995 · 55 citations

, , +14

Increasing Exposure to Drug-Drug Interactions Between 1992 and 2005 in People Aged ≥55 Years

Matthijs L. Becker, Loes E. Visser, Teun van Gelder et al. · Drugs & Aging · 2008 · 49 citations

, , +14

1–5 of 16

Authors

122

  1. LB
    Leslie Bernstein

    University of Southern California, United States

    2 publications · 75 citations

    2

    h-index

  2. GU
    Giske Ursin

    University of Southern California, United States

    1 publications · 31 citations

    1

    h-index

  3. SG
    Selene G. Huerta-Olvera

    Universidad de Guadalajara, Mexico

    1 publications · 17 citations

    1

    h-index

  4. SA
    Sandra A. Norman

    University of Pennsylvania, United States

    1 publications · 31 citations

    1

    h-index

  5. LM
    Liam Murray

    Queen's University Belfast, United Kingdom

    1 publications · 44 citations

    1

    h-index

1–5 of 122

Institutions

70

  1. Fred Hutch Cancer Center

    Seattle, United States

    2 h-index

    3 publications

    106 citations

  2. University of Pennsylvania

    Philadelphia, United States

    2 h-index

    10 publications

    359 citations

  3. University of Southern California

    Los Angeles, United States

    2 h-index

    3 publications

    106 citations

  4. City of Hope

    Lancaster, United States

    1 h-index

    1 publications

    44 citations

  5. The Barbara Ann Karmanos Cancer Institute

    Detroit, United States

    1 h-index

    1 publications

    31 citations

  6. Universitat Autònoma de Barcelona

    Cerdanyola del Vallès, Spain

    1 h-index

    1 publications

    91 citations

  7. Karolinska Institutet

    Stockholm, Sweden

    1 h-index

    1 publications

    44 citations

  8. E Ink (Taiwan)

    Hsinchu, Taiwan

    1 h-index

    3 publications

    69 citations

1–8 of 70

Venues

  1. Drugs & Aging

    2 publications · 140 citations

    2

    h-index

  2. Diabetes Metabolic Syndrome and Obesity

    1 publications · 100 citations

    1

    h-index

  3. Medicine

    1 publications · 23 citations

    1

    h-index

  4. Cancer Epidemiology Biomarkers & Prevention

    CEBP · 1 publications · 31 citations

    1

    h-index

  5. Neuroepidemiology

    1 publications · 12 citations

    1

    h-index

1–5